chr8-144515871-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004260.4(RECQL4):c.1151G>A(p.Arg384Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000595 in 1,612,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152208Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000810 AC: 20AN: 246876Hom.: 0 AF XY: 0.0000595 AC XY: 8AN XY: 134492
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1460616Hom.: 0 Cov.: 66 AF XY: 0.0000385 AC XY: 28AN XY: 726564
GnomAD4 genome AF: 0.000250 AC: 38AN: 152208Hom.: 0 Cov.: 34 AF XY: 0.000215 AC XY: 16AN XY: 74368
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
- -
Rothmund-Thomson syndrome;C0265308:Baller-Gerold syndrome;C1849453:Rapadilino syndrome Uncertain:1
- -
Rothmund-Thomson syndrome type 2 Uncertain:1
The RECQL4 c.1151G>A (p.Arg384Gln) missense change has a maximum subpopulation frequency of 0.096% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/8-145741255-C-T?dataset=gnomad_r2_1). In silico tools predict a benign effect of this variant on protein function (BP4), but to our knowledge these predictions have not been confirmed by functional assays. This variant has been reported in an individual with multiple cancers including cutaneous melanoma diagnosed at age 60 years, Non-Hodgkin lymphoma diagnosed at age 68 years, and bronchus diagnosed at age 73 years (PMID: 29641532). To our knowledge, this variant has not been reported in individuals with RECQL4-associated disorders. In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: BP4. -
Baller-Gerold syndrome Benign:1
- -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at